All In MedTech

Device Trial Radar · NCT07928908

Transcranial Magnetic Therapy (TMS) for Treatment of Perinatal Depression

TRANSCRANIAL MAGNETIC THERAPY (TMS) FOR TREATMENT OF PERINATAL DEPRESSION

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 23, 2026

Primary completion

Sep 2028

Study completion May 2029

Sponsor

Lead sponsor
Rana JawishAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 10, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the use of transcranial magnetic stimulation (TMS) to treat depression during pregnancy and the first year after childbirth. TMS is a noninvasive treatment that uses magnetic pulses applied to the scalp to stimulate areas of the brain involved in depression. The main goal of the study is to determine whether TMS treatment is feasible, acceptable, and safe for women with perinatal depression. The study will also collect preliminary information about whether TMS reduces symptoms of depression and whether improvements are maintained after treatment. Up to 100 women age 22 years and older who have major depression and are either 12 to 28 weeks pregnant or within 12 months after giving birth will participate. All participants will receive TMS; there is no placebo or comparison group. Participants will receive 20 to 36 TMS treatment sessions over approximately 4 to 8 weeks, with up to five sessions per week. Depression and other mental health symptoms, treatment attendance, satisfaction with treatment, and safety will be assessed before, during, and approximately one month after TMS treatment. The study hypothesis is that TMS will be a feasible and acceptable treatment for women with perinatal depression, as shown by participants completing and adhering to treatment, acceptable treatment satisfaction, and appropriate safety outcomes. The study will also explore whether depressive symptoms improve during TMS treatment and whether improvement is sustained one month after treatment. For women who participate while pregnant, the study team will review maternal and infant medical records approximately six months after delivery to assess pregnancy, delivery, postpartum, and infant health outcomes.

Conditions

  • Perinatal Depression

Interventions

  • Transcranial Magnetic Stimulation (TMS)Device

    Participants will receive active transcranial magnetic stimulation (TMS) using the NeuroStar TMS system, targeting the left dorsolateral prefrontal cortex (DLPFC). Treatment will use FDA-cleared stimulation parameters for major depressive disorder, including standard repetitive TMS (rTMS) at 10 Hz (3,000 pulses per session) or intermittent theta burst stimulation (iTBS; 600 pulses per session). Stimulation intensity will be set at 80-120% of each participant's resting motor threshold. Participants will receive one session per day, up to five days per week, for a total of 20-36 sessions over 4-8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retention RateTime frame: 8 weeks post baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huntsman Mental Health Institute

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.